Intriguingly, human mutations in AT2 are also reported to result in XLID and epilepsy and might have overlapping clinical features with NHE6 mutations (Vervoort et al., 2002; Takeshita et al., 2012). The gene discussed is SLC9A6; the disease is epilepsy.